Welcome to our dedicated page for Life360 SEC filings (Ticker: LIF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Life360, Inc. filings document regulatory disclosures for a Delaware technology company whose common stock trades on Nasdaq under LIF. Form 8-K reports furnish operating and financial results, Regulation FD presentation materials, material-event disclosures, material agreements, shareholder voting matters and capital-structure information.
Proxy materials describe board and executive compensation matters, equity awards, corporate governance and voting procedures. The filing record also reflects disclosure areas tied to Life360’s family safety platform, subscription metrics, advertising initiatives, legal and compliance oversight, and public-company securities reporting.
Life360, Inc. (LIF) director John Philip Coghlan, through the John Coghlan Living Trust, reported selling 4,000 shares of common stock on September 1, 2026 at a weighted average price of $41.97 per share, in transactions priced between $41.72 and $42.21 per share.
The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. Following the sale, the John Coghlan Living Trust held 16,431 shares indirectly, Coghlan held 5,676 shares directly (including 4,840 restricted stock units), and The John Philip Coghlan 2025 Grantor Retained Annuity Trust held 55,494 shares indirectly.
Life360, Inc. (LIF) director James Synge reported open-market sales of the company’s common stock, executed via CHESS Depositary Interests (CDIs) traded on the Australian Securities Exchange. On 2026-08-26, he sold 27,466 common-stock-equivalent shares at a weighted average price of $44.31 per share, with individual sale prices ranging from $44.169 to $44.557. On 2026-08-25, he sold 5,833 common-stock-equivalent shares at a weighted average price of $45.05 per share. The prices were derived from CDI trades using the 3:1 CDI-to-common-stock conversion ratio and exchange rates of 0.715 and 0.7182, respectively. Reported holdings include 4,600 RSUs, each representing one share of common stock upon vesting, and also include common stock underlying CDIs on the same 1:3 basis.
Life360, Inc. (LIF) filed a Form D for a private exempt offering of equity securities under Regulation D Rule 506(b). The notice is a new filing, with the first sale on 2026-08-10. The company reports $600,000 USD total amount sold and $0 USD remaining to be sold, indicating the offering was fully subscribed. The transaction is described as an offering made pursuant to an Asset Purchase Agreement. Life360 indicates a revenue range of over $100,000,000, placing it in the largest issuer size category on the form. No finders’ fees were paid in connection with the offering, with finders' fees disclosed as $0 USD.
Life360, Inc. (LIF) director Synge James reported option exercises and related share issuances on August 19, 2026. James exercised stock options for 12,203 shares of common stock at an exercise price of $13.35 per share and 21,769 shares at $8.19 per share, with the underlying options fully vested and exercisable. The transactions moved 33,972 shares from derivative (option) holdings into common stock. Footnotes state that reported direct ownership includes 4,600 RSUs and shares underlying Chess Depositary Interests, which trade on the Australian Securities Exchange.
Life360, Inc. (LIF) director Chris Hulls reported a series of option exercises and share sales on 2026-08-18. He exercised stock options for a total of 212,502 shares of common stock at exercise prices of $2.53, $7.28 and $8.19 per share, from fully vested options. On the same date he sold 250,000 shares of common stock in open-market transactions at weighted average prices of $46.78 and $47.58 per share, with individual sale prices ranging from $46.36–$48.30 per share. Following these transactions, indirect holdings of 195,312 shares of common stock are reported for each of three 2023 irrevocable trusts, which represent shares underlying Chess Depositary Interests.
Life360, Inc. (LIF) received a notice under Rule 144 that director Christopher Hulls, through an account at Fidelity Brokerage Services LLC, may sell up to 250,000 shares of common stock. These shares are tied to restricted stock vesting and stock option exercises scheduled between December 2025 and August 2026. The notice lists an aggregate market value of $11,708,952.38 for the 250,000 shares, based on trading on NASDAQ, with a stated trading volume of 81,480,369 shares as of August 18, 2026.
Life360, Inc. director Charles J. Prober exercised a fully vested stock option for 7,930 shares of common stock at an exercise price of $11.18 per share, leaving 23,790 option shares outstanding. He then sold 7,930 common shares at $48.59 per share on the same date. The transactions were executed under a Rule 10b5-1 trading plan adopted on March 14, 2025. Reported equity holdings include 4,474 restricted stock units, each representing one future share upon vesting.
Charles Prober filed to sell 7,930 shares of common stock on 08/13/2026, to be delivered from a stock option exercise and held in an account at Fidelity Brokerage Services LLC, with trading on NASDAQ. The filing also lists prior sales of 7,930 shares of common stock on each of 05/13/2026, 06/15/2026, and 07/13/2026, for aggregate proceeds of $320,689.20, $365,335.10, and $420,686.50, respectively.
Life360, Inc. director Brit Morin reported an option exercise-and-sale sequence on August 10, 2026. She exercised stock options for a total of 9,765 shares of common stock at exercise prices of $2.15 and $8.19 per share, then sold 15,582 shares of common stock at $65.00 per share. A footnote states these transactions were made under a Rule 10b5-1 trading plan adopted on March 13, 2026, and that the reporting person’s holdings include 4,636 restricted stock units representing contingent rights to receive common shares upon vesting.
Brittany B. Morin filed a notice of proposed sale of restricted securities, indicating an intention to sell up to 15,582 shares of common stock through Fidelity Brokerage Services LLC on or after August 10, 2026, with an aggregate market value of $1,012,830.00 and listing on NASDAQ. The shares derive from a stock option exercise of 9,765 shares on August 10, 2026 and multiple restricted stock vestings between September 2020 and June 2026. Over the past three months, Morin has sold 4,655 shares for $257,125.00 on June 29, 2026 and 10,701 shares for $642,060.00 on August 4, 2026.